HIV persists in a reservoir of latently infected CD4 + T cells in individuals treated with highly
active antiretroviral therapy (HAART). Here we identify central memory (T CM ) and …

The engagement of programmed death 1 (PD-1) to its ligands, PD-L1 and PD-L2 1 , 2 , 3 , 4
, inhibits proliferation and cytokine production mediated by antibodies to CD3 (refs. 5 , 6 , 7 ). …

Viral replication and microbial translocation from the gut to the blood during HIV infection
lead to hyperimmune activation, which contributes to the decline in CD4 + T cell numbers …

Correlates of immune-mediated protection to most viral and cancer vaccines are still unknown.
This impedes the development of novel vaccines to incurable diseases such as HIV and …

CD4 + T cell responses are associated with disease control in chronic viral infections. We
analyzed human immunodeficiency virus (HIV)-specific responses in ten aviremic and eight …

The world of human immunodeficiency virus (HIV) vaccines has suffered a baffling setback.
The first trial of a vaccine designed to elicit strong cellular immunity has shown no protection …

<p>Human immunodeficiency virus (HIV) persistence in latently infected resting memory
CD4+ T-cells is the major barrier to HIV cure. Cellular histone deacetylases (HDACs) are …

HIV persists in a small pool of latently infected cells despite antiretroviral therapy (ART).
Identifying cellular markers expressed at the surface of these cells may lead to novel therapeutic …

Apoptosis induced by T cell receptor (TCR) triggering in T lymphocytes involves activation
of cysteine proteases of the caspase family through their proteolytic processing. Caspase-3 …

There is limited knowledge on the identity of primary CD4+ T cell subsets selectively
targeted by HIV-1 in vivo. In this study, we established a link between HIV permissiveness, …